As in many areas of health care, treatments for cancer may differ only moderately in their effects on major end points, such as death. But, such differences are worth knowing about, particularly in common diseases in which they could represent a substantial benefit to public health. Large-scale randomized evidence allows moderate differences to be investigated reliably, and one way to achieve this is by meta-analyses of updated and centrally collected individual patient data from all relevant...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Individual patient data meta-analysis in cancer.
If you are the owner of this record, you can report an update to it here: Report update to this record